Our Vision
Luoda has a clear commercialization strategy at the core of its business. This strategy is largely driven by Luoda’s historical association with Bova Aus, Australia’s largest veterinary compounder. A number of the products that Luoda is taking through the registration process have their origins as animal health compounding products that have been successfully selling on a compounded basis for many years. The success of a compounded product means that the market for the registered version has been validated, providing confidence prior to registration that the product will be a commercial success.
The constraints on the R&D budgets of Pharma means they are increasingly looking to partner with small pharma start-ups who can deliver innovations rapidly in order to expedite product development and registration. Luoda recognizes that strong partnerships with Pharma are extremely important, and in many cases, are necessary to maximise commercial success and returns. In partnership, Pharma offers Luoda brand recognition, funding and the ability to penetrate and distribute into international markets.
To pull, not push
Our R&D investments are, from the outset, informed by the clinical unmet needs of our target species. We gain this knowledge through our close contact with veterinarians.
To be agile
As a virtual pharmaceutical Luoda has low overheads, with the vast majority of its spend being on R&D, targeting significant formulation changes of existing actives to improve clinical outcomes thereby reducing time and risk of the product registration process.
To partner with Big Pharma
Luoda targets partnerships with global pharmaceutical companies to leverage our intellectual property and R&D capabilities with Pharma’s brand recognition, funding and ability to penetrate and distribute into international markets.